BOLD Latest Press Releases

-- April 17, 2026 --

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting Globe Newswire 4:49 PM

-- March 17, 2026 --

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026 Globe Newswire 4:52 PM

-- March 9, 2026 --

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- March 4, 2026 --

Boundless Bio to Participate in the Leerink Global Healthcare Conference Globe Newswire 7:00 AM

-- March 2, 2026 --

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight PRNewswire 5:31 PM

-- February 5, 2026 --

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Globe Newswire 7:00 AM

-- January 20, 2026 --

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software